Patents by Inventor Paul Bulpitt

Paul Bulpitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070149441
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Application
    Filed: February 13, 2007
    Publication date: June 28, 2007
    Applicant: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt
  • Patent number: 7196180
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: March 27, 2007
    Assignee: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt
  • Publication number: 20050222083
    Abstract: The present invention relates to biscarbodiimides, thiourea derivatives, urea derivatives, and cross-linked hyaluronan derivatives having at least one intramolecular disulfide bond, and methods of preparation thereof. The invention also includes thiolated hyaluronan derivatives and salts thereof having at least one pendant thiol group or a modified pendant thiol group, and methods of preparation thereof. An example of a modified pendant thiol group is a sulfhydryl group linked to a small molecule such as a bioactive agent, for example a drug or pharmaceutically active moiety. A hyaluronan derivative having a sulfhydryl group linked to a pharmaceutically active moiety is useful as a sustained or controlled release drug delivery vehicle. Compositions containing the hyaluronan derivatives of the invention can reversibly viscosify in vivo or in vitro, in response to mild changes in condition, and are thus useful in ophthalmic surgery and in tissue engineering.
    Type: Application
    Filed: February 15, 2005
    Publication date: October 6, 2005
    Applicant: Anika Therapeutics, Inc.
    Inventors: Paul Bulpitt, Charles Sherwood, Khalid Sadozai
  • Publication number: 20040072793
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Application
    Filed: October 6, 2003
    Publication date: April 15, 2004
    Applicant: ORTHOGENE, L L C.
    Inventors: Daniel Aeschlimann, Paul Bulpitt
  • Patent number: 6630457
    Abstract: Methods for chemical modification of hyaluronic acid, formation of amine or aldehyde functionalized hyaluronic acid, and the cross-linking thereof to form hydrogels are provided. Functionalized hyaluronic acid hydrogels of this invention can be polymerized in situ, are biodegradable, and can serve as a tissue adhesive, a tissue separator, a drug delivery system, a matrix for cell cultures, and a temporary scaffold for tissue regeneration.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: October 7, 2003
    Assignee: Orthogene LLC
    Inventors: Daniel Aeschlimann, Paul Bulpitt